Posted In: Entrepreneur
With an appetite for knowledge and a drive for success, Jack Plotkin has continuously found himself at the forefront of emerging technologies and industry change. Jack, a graduate of Harvard University, has spent nearly 20 years working with healthcare companies and almost seven years in the cauldron of healthcare’s technological advancements. In that time, he has become a recognized industry thought leader and a driving force behind cutting edge healthcare technologies.
Dr. Mark Holterman received training for running his own business while growing up on a farm in Wisconsin where he also helped his father run his construction business. He was exposed to the challenges that business owners face at that time, but he also was privileged to enjoy the rewards. He cherishes his days on the farm, but he had other dreams, so when he was accepted at Yale University, he gladly left Wisconsin. Dr. Mark Holterman graduated from Yale with honors.
Amicus Therapeutics recently announced that they are seeking FDA approval for a new drug therapy designed to provide effective treatment for the rare condition called Fabry disease. What is Fabry disease and what does this rare condition entail? How does this new medication help control bothersome symptoms associated with Fabry disease? What is Amicus Therapeutics and what do they specialize in? The following information has been designed to answer these important questions.